Funding awarded
- B cell determinants of EBV latency awarded by National Cancer Institute Key Personnel 2022 - 2027
- Defining the evolution and tumor microenvironment interactions of classic Hodgkin lymphoma through single-cell multi-omics and genetically engineered mouse models Key Personnel 2022 - 2024